Analysed GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) News Sources
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
31-03-2026
yahoo.com
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
09-04-2026
yahoo.com
Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers
14-04-2026
yahoo.com
Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics
06-05-2026
yahoo.com
Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mg
14-05-2026
yahoo.com
Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis
02-06-2026
yahoo.com
Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
08-06-2026
yahoo.com
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
22-06-2026
yahoo.com
Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol
16-07-2026
yahoo.com
What is the current price of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The current price of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is $0.5532.
GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) since the previous trading day is $0.0397.
GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) since the previous trading day is 7.7313%.
What is the most recent average sentiment score for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The most recent average sentiment score for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)?
The most recent sentiment for GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ) is .
SEC-8K** Filing Available For GALMED PHARMACEUTICALS LTD (GLMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.